ARMISTICE CAPITAL LLC 13D/13G Filings for Quoin Pharmaceuticals, Ltd. (QNRX)

ARMISTICE CAPITAL LLC 13D and 13G filings for Quoin Pharmaceuticals, Ltd.:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Shares have been adjusted for stock splits.
Time period
Reported
DateTime
Transaction
Date
TypeCompany
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev ReportView
2025-05-15
3:40 pm
Purchase
2025-03-3113GQuoin Pharmaceuticals, Ltd.
QNRX
ARMISTICE CAPITAL LLC1,081,183
4.990%
1,081,183increase
(New Position)
Filing